Trafficking of CAR T-cells into fibrotic tumor beds remains a significant hurdle in PDAC, and the incorporation of chemokine receptors (e.g., CCR2b, CXCR2) into CAR constructs has improved homing to tumor sites in murine models [129]. Here, CCR2 is linked to neoplasm.